Literature DB >> 29516555

Methamphetamine psychosis: insights from the past.

Rebecca McKetin1,2.   

Abstract

BACKGROUND AND AIMS: To review early case reports and experimental inductions of amphetamine and methamphetamine psychosis, prior to the prohibition of these drugs, to gain a better understanding of the nature and aetiology of methamphetamine psychosis.
METHODS: Papers considered were historical case reports and case series of psychosis relating to the use and misuse of prescription amphetamine, focusing upon papers by Young & Scoville (1938), Connell (1958), and three subsequent experimental studies published in the early 1970s (Griffith 1972, Angrist & Gershon 1970 and Bell 1973), where psychosis was induced in volunteers using high-dose amphetamine and methamphetamine.
RESULTS: High-dose methamphetamine and amphetamine can result in a paranoid psychosis which remits rapidly (within days) of discontinuing use. The central feature is paranoia occurring in a clear state of consciousness. This may be accompanied by other psychotic symptoms (e.g. hallucinations). Pre-existing schizophrenia is not necessary, and the syndrome is not due to sleep deprivation.
CONCLUSIONS: Research findings from the 1930s to the 1970s suggest that paranoid psychosis should be considered a probable consequence of high-dose methamphetamine use. Individuals who experience psychotic symptoms for any substantive period after intoxication has ended should be suspected of having a functional non-organic psychosis, or a latent vulnerability thereto.
© 2018 Society for the Study of Addiction.

Entities:  

Keywords:  Amphetamine; methamphetamine; paranoia; psychosis; schizophrenia; substance-induced psychosis

Mesh:

Substances:

Year:  2018        PMID: 29516555     DOI: 10.1111/add.14170

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  6 in total

1.  Assessing the mediating role of impulsivity between methamphetamine-induced psychotic disorders and increased gambling severity in methamphetamine-dependent individuals.

Authors:  Huixi Dong; Yidong Shen; Wei Hao
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-08-16       Impact factor: 5.760

2.  Latent Psychotic Symptom Profiles Amongst People Who Use Methamphetamine: What Do They Tell Us About Existing Diagnostic Categories?

Authors:  Rebecca McKetin; Alexandra Voce; Richard Burns; Robert Ali; Dan I Lubman; Amanda L Baker; David J Castle
Journal:  Front Psychiatry       Date:  2018-11-19       Impact factor: 4.157

Review 3.  mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.

Authors:  Larisa Ryskalin; Fiona Limanaqi; Alessandro Frati; Carla L Busceti; Francesco Fornai
Journal:  Int J Mol Sci       Date:  2018-07-30       Impact factor: 5.923

4.  "Complexity, safety and challenges: Emergency responders' experience of people affected by methamphetamines".

Authors:  Rikki Jones; Debra Jackson; Cindy Woods; Kim Usher
Journal:  Nurs Health Sci       Date:  2022-08-08       Impact factor: 2.214

Review 5.  A Comparison of Methamphetamine-Induced Psychosis and Schizophrenia: A Review of Positive, Negative, and Cognitive Symptomatology.

Authors:  Travis A Wearne; Jennifer L Cornish
Journal:  Front Psychiatry       Date:  2018-10-10       Impact factor: 4.157

6.  Paranoia, sensitization and social inference: findings from two large-scale, multi-round behavioural experiments.

Authors:  J M Barnby; Q Deeley; O Robinson; N Raihani; V Bell; M A Mehta
Journal:  R Soc Open Sci       Date:  2020-03-11       Impact factor: 2.963

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.